| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 6 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.66M | - | |
| CFO | 58.4K | $16.73M | - | |
| VP | 29.8K | $8.52M | - | |
| VP | 23.7K | $6.78M | - | |
| Dir | 23.2K | $6.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2015 | Maraganore John | Chief Executive Officer | Sale+OE | 58,689 | $104.87 | $6,154,715.34 | -7.1% | |
| Nov 20, 2015 | Maraganore John | Chief Executive Officer | Sale+OE | 8,070 | $103.97 | $839,022.57 | -5.7% |